Nexus Investment Management ULC
Source: SEC Form 13F · as of Mar 2026Nexus Investment Management ULC holds 11 biotech & pharma companies tracked by BioSniper, totaling $69.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$69.0M
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 254,722 | $35.5M |
| PFEPFIZER INC | 1,030,855 | $28.9M |
| JNJJOHNSON & JOHNSON | 8,381 | $2.0M |
| ABBVAbbVie Inc. | 3,456 | $752K |
| LLYELI LILLY & Co | 799 | $735K |
| MRKMerck & Co., Inc. | 3,735 | $449K |
| ABTABBOTT LABORATORIES | 2,490 | $256K |
| BIIBBIOGEN INC. | 920 | $169K |
| BMYBRISTOL MYERS SQUIBB CO | 953 | $58K |
| BHCBausch Health Companies Inc. | 8,500 | $46K |
| NVSNovartis AG | 220 | $34K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.